関連する実験動画

Updated: Nov 9, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

薬剤師による高血圧治療の費用対効果

Kelsey B Bryant¹, Andrew E Moran¹, Dhruv S Kazi^2,3

¹Columbia University, Vagelos College of Physicians and Surgeons, New York, NY (K.B.B., A.E.M., Y.Z., L.P.C., B.K.B.).

|April 15, 2021

まとめ

薬剤師による高血圧治療は黒人男性の血圧コントロールを大幅に改善しましたこの10年間の予測はロサンゼルス理髪店の血圧研究 (LABBPS) の介入が非常に費用対効果的で健康的な結果を改善していることを示しています

科学分野:

公衆衛生
心血管医学
健康経済

背景:

ロサンゼルスの理髪店の血圧研究 (LABBPS) は,黒人所有の理髪店での薬剤師主導の高血圧管理が,血圧制御を改善したことを実証しました.
この分析は,LABBPSの介入に関連する長期的な健康結果と医療費を予測しています.

研究の目的:

薬剤師主導の高血圧治療の10年間の健康成果と医療費を標準的なケアと比較して予測する.
医療部門の観点からLABBPSの費用対効果を評価する.

主な方法:

血圧,有害事象,心血管疾患,死亡率を含む高血圧ケアプロセスをモデル化した離散イベントシミュレーション.
予測されたコスト,品質調整寿命 (QALY) および費用対効果は,年間3%の割引率で10年の期間で推定された.

主要な成果:

LABBPSの介入は,参加者1人あたり2356ドル以上になるが,10年間で0.06のQALYを得ると予測されている.
この介入は,高コスト効率で,獲得したQALYあたり42,717ドルで,高コスト効率になる確率は58%であった.
ジェネリック医薬品のみを使用すると QALY17,162ドルの費用対効果が向上しました

結論:

黒人の理髪店で提供される薬剤師主導の高血圧治療は,黒人の男性の血圧制御を改善するための非常に費用対効果の高い戦略です.
LABBPSモデルは,支援不足の地域における高血圧の管理に拡張可能で効果的なアプローチを提供します.

キーワード:

床屋さん血圧コスト・ベネフィット分析高血圧

さらに関連する動画

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

関連する概念動画

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Hypertension V: Nursing Management

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Errors occurring during blood pressure monitoring

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...

Blood Pressure

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...